Clear and present data: identifying barriers to clinical trial transparency
What’s standing in the way of researchers adopting good practices on clinical trial data sharing and transparency?
Reporting of many clinical trials ruled illegal
A US court ruling finds reporting of many clinical trials of unapproved drugs in breach of the law. But responses to the ruling are uncertain.
Less than half of US clinical trials report results on ClinicalTrials.gov on time
Less than half of trials on clinicaltrials.gov meet the FDAAA results reporting deadline in a study from Ben Goldacre’s EBM DataLab at Oxford University
[VIDEO] Commitments by the biopharmaceutical industry to clinical trial transparency: the evolving environment
Gemma Rogers, Communications Director at Oxford Pharmagenesis, discusses a study on clinical trial transparency.
Are European universities failing to report clinical trial data in a timely manner?
A recent article from Nature news delves into clinical trial reporting following evidence showing that some universities are failing to meet EU regulations.
Disparities claimed between stance and action on clinical trial outcome reporting by top medical journals
Selective reporting of clinical trial outcomes may be widespread. This study reports instances occurring in CONSORT-endorsing medical journals.
Are researchers able to access trial data? Audit provides insights on data sharing from industry-sponsored studies
A recent study published in BMC Medicine audits data sharing from pharmaceutical industry-sponsored clinical studies.
The elimination of negative study results: reporting and citation bias
Is the apparent efficacy of treatments being altered by bias? A recent study takes a closer look at the cumulative effects of reporting and citation biases.
Google launches Dataset Search
Google launches a new search tool to facilitate the discoverability of public datasets.
New EU trials tracker reveals that half of European clinical trials have broken reporting rules
Is your institute breaking European clinical trial reporting rules? Find out using the new EU trials tracker, part of the AllTrials initiative.
Meeting report: summary of the 14th Annual Meeting of ISMPP – Part 2
Missed the 14th Annual Meeting of ISMPP? Read the second part of our meeting report to get up to speed!
Clinical trial transparency: are non-commercial funders lagging behind industry sponsors?
A new study from the AllTrials team sheds light on clinical trial reporting rates by non-industry sponsors.
A new series from The BMJ highlights unreported trials
A new, regular series in The BMJ will highlight a different unreported clinical trial every week, with the intention of improving reporting rates.
What proportion of clinical trial data is reported? TrialsTracker launches new monitoring tool
The FDAAA 2007 requires clinical trials to make results publicly available 12 months after study completion. A new tool from TrialsTracker provides a live online report on compliance.
Meeting report: summary of day 1 of the 2018 Annual TIPPA Meeting
Missed TIPPA 2018? Read our meeting report to get up to speed!
[VIDEO] ISMPP European Meeting 2018: conference summary (day 2)
Missed ISMPP EU 2018? Duncan Campbell provides a summary of day 2 of the meeting.